We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Jones Soda Q3 2026: 126 Million Shares Outstanding

Jones Soda Co. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 10, 2026, reporting 126,028,350 shares of common stock issued and outstanding as of that date.

Aditi Sarkar | 10 November 2026

Morgan Stanley MSFL Worst-of RTY SPX Jump Notes Due Dec 2027

Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 20,018 on November 10, 2026, covering Worst-of RTY and SPX Enhanced Trigger Jump Securities due December 30, 2027.

Nitish Kishor | 10 November 2026

Erin Burr Acquires 183.70 FS Bancorp Shares via Stock Purchase Plan

Erin Burr, CRO and CRA Officer and Executive Vice President of FS Bancorp, Inc., filed a Form 4 on November 9, 2026, disclosing a transaction in the company's common stock dated November 6, 2026.

Nitish Kishor | 10 November 2026

MasterCraft Q1 FY2027: Net Sales Rise to $154.1M

MasterCraft Boat Holdings, Inc. filed its Form 10-Q with the SEC on November 10, 2026, covering the fiscal first quarter ended October 4, 2026, and reporting net income of $12.1 million on net sales of $154.1 million.

Shwetambri Chauhan | 10 November 2026

Adelson Disposes 2,344 Jack Henry Shares via Gift

Gregory R. Adelson, President and CEO of Jack Henry & Associates Inc, filed a Form 4 on November 10, 2026, disclosing a disposition of 2,344 shares of common stock on November 6, 2026.

Anjali Anand | 10 November 2026

Daewoong Exercises Pre-Funded Warrants in AEON Biopharma

Daewoong Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. filed Amendment No. 1 to Schedule 13D with the SEC on November 10, 2026, reporting the October 30, 2026 cashless exercise in full of Pre-Funded Warrants in AEON Biopharma, Inc. and the resulting changes in beneficial …

Nitish Kishor | 10 November 2026

Mullet Acquires 183.70 FS Bancorp Shares via Stock Purchase Plan

Matthew D. Mullet, President and CEO of FS Bancorp, Inc. (NASDAQ:FSBW), filed a Form 4 on November 9, 2026, disclosing a transaction dated November 6, 2026, involving the acquisition of common stock under the company's Nonqualified 2022 Stock Purchase Plan.

Anjali Anand | 10 November 2026

Arlo Director Faison Buys 8,250 Shares at $12.17

A Form 4 filed on November 10, 2026 with the SEC reports that Ralph E. Faison, a director of Arlo Technologies, Inc. (NASDAQ:ARLO), purchased 8,250 shares of common stock on November 9, 2026.

Shwetambri Chauhan | 10 November 2026

Whittington Acquires 86 Shares via FS Bancorp Stock Plan

Phillip Dean Whittington, Chief Financial Officer of FS Bancorp, Inc. (NASDAQ:FSBW), filed a Form 4 on November 9, 2026, disclosing a transaction in the company's common stock dated November 6, 2026.

Anjali Anand | 10 November 2026

LifeStance Director Burdick Plans Sale of 75,000 Shares

Kenneth A. Burdick, a director of LifeStance Health Group, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 75,000 shares of common stock following a stock option exercise.

Anjali Anand | 10 November 2026
Support

Hi! How can we help you today?

Loading…